Sign Out
Menactra is administered as a single 0.5 mL injection by the intramuscular route, preferably in the anterolateral thigh or deltoid region depending on the recipient's age and muscle mass.
Primary vaccination: In children 9 through 23 months of age who travel or living in endemic areas. Menactra is given as a 2-dose series at least three months apart.
Individuals 2 through 55 years of age receive a single dose.
Do not administer this product intravenously, subcutaneously, or intradermally. The need for, or timing of, a booster dose of Menactra vaccine has not yet been determined. Parenteral drug products should be inspected visually for container integrity, particulate matter, and discoloration prior to administration, whenever solution and container permit.
Lanjutkan dengan Google